Longboard pharmaceuticals to participate in upcoming investor conferences

San diego, sept. 01, 2022 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior leadership team will participate in the citi annual biopharma conference, which is taking place september 7-8, 2022, in boston, ma, and participate in a fireside chat at the h.c. wainwright global investment conference, which is taking place september 12-14, 2022, in new york city.
LBPH Ratings Summary
LBPH Quant Ranking